References
- Y L, R S, J Z, et al. miR-506 inhibits the proliferation and invasion by targeting IGF2BP1 in glioblastoma. Am J Transl Res. 2015;7:2007–2014.
- Chen R, Smith-Cohn M, Cohen AL, et al. Glioma subclassifications and their clinical significance. Neurotherapeutics. 2017;14(2):284–297.
- Reardon DA, Wen PY. Glioma in 2014: unravelling tumour heterogeneity-implications for therapy. Nat Rev Clin Oncol. 2015;12(2):69–70.
- Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–233.
- Peng Y, Croce CM. The role of MicroRNAs in human cancer. Signal Transduct Target Ther. 2016;1(1):15004.
- Manikandan J, Aarthi JJ, Kumar SD, et al. Oncomirs: the potential role of non-coding microRNAs in understanding cancer. Bioinformation. 2008;2(8):330–334.
- Chen W, Qi J, Bao G, et al. Emerging role of microRNA-27a in human malignant glioma cell survival via targeting of prohibitin. Mol Med Rep. 2015;12(1):1515–1523.
- Banelli B, Forlani A, Allemanni G, et al. MicroRNA in glioblastoma: An overview. Int J Genomics. 2017;(2017):7639084.
- Henriksen M, Johnsen KB, Andersen HH, et al. MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme–a systematic overview. Mol Neurobiol. 2014;50(3):896–913.
- Wang D, Zhu C, Zhang Y, et al. MicroRNA-30e-3p inhibits cell invasion and migration in clear cell renal cell carcinoma by targeting Snail1. Oncol Lett. 2017;13(4):2053–2058.
- Gramantieri L, Pollutri D, Gagliardi M, et al. MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma. Cancer Res. 2020;80(8):1720–1734.
- Hatta K, Guo J, Ludke A, et al. Expression of CNPY2 in mouse tissues: quantification and localization. PLoS One. 2014;9(11):e111370.
- Yan P, Gong H, Zhai X, et al. Decreasing CNPY2 expression diminishes colorectal tumor growth and development through activation of p53 pathway. Am J Pathol. 2016;186(4):1015–1024.
- Ito S, Ueno A, Ueda T, et al. CNPY2 inhibits MYLIP-mediated AR protein degradation in prostate cancer cells. Oncotarget. 2018;9(25):17645–17655.
- Peng J, Ou Q, Pan Z, et al. Serum CNPY2 isoform 2 represents a novel biomarker for early detection of colorectal cancer. Aging (Albany NY). 2018;10(8):1921–1931.
- Yu D, Qin Y, Jun-Qiang L, et al. CNPY2 enhances resistance to apoptosis induced by cisplatin via activation of NF-kappaB pathway in human non-small cell lung cancer. Biomed Pharmacother. 2018;103:1658–1663.
- Zhang J, Stevens MF, Laughton CA, et al. Acquired resistance to temozolomide in glioma cell lines: molecular mechanisms and potential translational applications. Oncology. 2010;78(2):103–114.
- Wang BC, Ma J. Role of MicroRNAs in malignant glioma. Chin Med J (Engl). 2015;128(9):1238–1244.
- Wang XT, Wu XD, Lu YX, et al. Potential involvement of MiR-30e-3p in myocardial injury induced by coronary microembolization via autophagy activation. Cell Physiol Biochem. 2017;44(5):1995–2004.
- Liu Y, Xu Y, Ding L, et al. LncRNA MEG3 suppressed the progression of ovarian cancer via sponging miR-30e-3p and regulating LAMA4 expression. Cancer Cell Int. 2020;20(1):181.
- Guo J, Zhang Y, Mihic A, et al. A secreted protein (Canopy 2, CNPY2) enhances angiogenesis and promotes smooth muscle cell migration and proliferation. Cardiovasc Res. 2015;105(3):383–393.
- Peng J, Ou Q, Guo J, et al. Expression of a novel CNPY2 isoform in colorectal cancer and its association with oncologic prognosis. Aging (Albany NY). 2017;9(11):2334–2351.
- Taniguchi H, Ito S, Ueda T, et al. CNPY2 promoted the proliferation of renal cell carcinoma cells and increased the expression of TP53. Biochem Biophys Res Commun. 2017;485(2):267–271.
- Dou Y, Lei JQ, Guo SL, et al. The CNPY2 enhances epithelial-mesenchymal transition via activating the AKT/GSK3beta pathway in non-small cell lung cancer. Cell Biol Int. 2018;42(8):959–964.
- Wang H, Kanmangne D, Li R, et al. miR30a3p suppresses the proliferation and migration of lung adenocarcinoma cells by downregulating CNPY2. Oncol Rep. 2020;43:646–654.
- Hashimoto Y, Akiyama Y, Yuasa Y. Multiple-to-multiple relationships between microRNAs and target genes in gastric cancer. PLoS One. 2013;8(5):e62589.